Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia
Clinical trial NCT01600053 · TERMINATED
Trial details
- NCT number
- NCT01600053
- Sponsor
- Thomas Kipps
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2014-05-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.